FDA Warns Online Retailers for Unauthorized Sale of E-Cigarette Products

Regulations by 2FIRSTS.ai
Feb.02.2024
FDA Warns Online Retailers for Unauthorized Sale of E-Cigarette Products
FDA Warns 14 Online Retailers for Selling Unauthorized E-Cigarette Products; Targets Brands Popular among Youth.

On February 1st, the official website of the US Food and Drug Administration (FDA) released a statement regarding warning letters sent to 14 online retailers. These letters accuse the retailers of selling unauthorized e-cigarette products. The warning pertains to disposable e-cigarette products under brands such as Elf Bar/EB Design, Lava Plus, Funky Republic/Funky Lands, Lost Mary, Cali Bars, Cali Plus, and Kangvape.

 

These warnings are based on continuous monitoring of multiple surveillance systems by the FDA, with the aim of identifying products that are popular or appealing among young people.

 

According to the National Youth Tobacco Survey of 2023, over 50% of teenagers are using the disposable e-cigarette brand Elf Bar. It is understood that in 2023, the manufacturer of Elf Bar started promoting the product under the name "EB Design".

 

Furthermore, the FDA has identified Lava Plus, Funky Republic/Funky Lands, Kangvape, Cali, and Breeze among the popular or appealing brands for young people, based on a review of retail sales data and internal surveys.

 

Retailers who have received these warning letters would be in violation of the Federal Food, Drug, and Cosmetic Act if they sell or distribute e-cigarette products in the United States without FDA authorization. The recipients of the warning letters have 15 working days to respond and must provide details of the actions they will take to correct the non-compliant behavior and prevent similar violations from occurring in the future. Failure to promptly rectify these violations could result in additional actions by the FDA, such as injunctions, seizures, and/or civil fines.

 

This series of warning letters represents the latest initiative by the FDA in collaboration with retailers to address the unauthorized marketing and sale of e-cigarettes targeting young people. As of January 30, 2024, the FDA has issued warning letters and 88 civil money penalty (CMP) notices to over 440 retailers selling illegal e-cigarettes, encompassing physical retail stores across the country.

 

As of now, the FDA has authorized 23 e-cigarette devices and tobacco-flavored e-cigarette products. For retailers looking for information on legally selling e-cigarettes, the FDA provides printable flyers in addition to the authorized product list on their website. Additionally, the FDA is developing a searchable public database that will include all tobacco products that have received marketing orders from the FDA.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.